Regenstrief Researcher Briefs FDA on Need for Patient Identity Management (IMAGE)
Caption
Regenstrief Institute research scientist Shaun Grannis, M.D. was one of several experts participating in a recent conference in Washington, D.C. to inform the U.S. Food and Drug Administration's (FDA) use of real-world data and evidence to support its regulatory decisions.
Credit
Duke-Margolis Center for Health Policy
Usage Restrictions
Credit to Duke-Margolis Center for Health Policy
License
Licensed content